CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Study of Nexvax2 Administered Subcutaneously After a Screening Gluten Food Challenge That Compares Relative Bioavailability With Intradermal Administration in Non-homozygous HLA-DQ2.5+ Adults With Celiac Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03543540
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:09.101793+00:00
Published At: 2018-09-20T00:00:00+00:00
Record Updated At: 2018-09-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Celiac Disease", "Intestinal Disease", "Malabsorption Syndromes", "Gastrointestinal Disease", "Digestive System Diseases", "Metabolic Disease", "Coeliac Disease", "Gluten Sensitivity"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-09-20"
protocolSection.identificationModule.nctId: "NCT03543540"
protocolSection.identificationModule.officialTitle: "A Phase 1 Study of Nexvax2 Administered Subcutaneously After a Screening Gluten Food Challenge That Compares Relative Bioavailability With Intradermal Administration in Non-homozygous HLA-DQ2.5+ Adults With Celiac Disease"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.